Dr. Reddy's unveils OTC Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg ERTablets in the US.
M2 EQUITYBITES-November 21, 2014-Dr. Reddy's unveils OTC Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg ERTablets in the US
(C)2014 M2 COMMUNICATIONS http://www.m2.com
Pharmaceutical company Dr. Reddy's Laboratories (NYSE:RDY) disclosed on Thursday the introduction of its US FDA approved over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg in a 20 count blister in the US market.
The company added the OTC Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg is the bioequivalent generic version of Allegra-D 12 Hour Allergy & Congestion.
According to IRI, Allegra-D 12 Hour brand has US sales of about USD49.8m for the latest 52 weeks ending 6 October 2014 for Total US Multi Outlet.
((Comments on this story may be sent to info@m2.com))
 Printer friendly
 Cite/link
 Email
 Feedback
| |
| Publication: | M2 EquityBites (EQB) |
|---|---|
| Date: | Nov 21, 2014 |
| Words: | 135 |
| Previous Article: | Kuka reaches 80.5% in Swisslog. |
| Next Article: | Advanced Emissions Solutions announces lease of another Refined Coal facility to an existing RC investor. |
| Topics: | |